

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Lead Product(s) : Sulodexide
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Alfasigma
Deal Size : Inapplicable
Deal Type : Inapplicable
Endothelial Protection in Post COVID-19 Patients With Sulodexide
Details : Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of COVID-19.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 12, 2022
Lead Product(s) : Sulodexide
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Alfasigma
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Sulodexide
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Alfasigma
Deal Size : Inapplicable
Deal Type : Inapplicable
Sulodexide in the Treatment of Chronic Primary Venous Disease of the Lower Extremities
Details : Vessel (Sulodexide) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Vascular Diseases.
Product Name : Vessel
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 13, 2021
Lead Product(s) : Sulodexide
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Alfasigma
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sulodexide
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II/ Phase III
Sponsor : Clinedem
Deal Size : Inapplicable
Deal Type : Inapplicable
Suloexide in the Treatment of Early Stages of COVID-19
Details : Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of COVID-19.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 23, 2020
Lead Product(s) : Sulodexide
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II/ Phase III
Sponsor : Clinedem
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sulodexide
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Poseidon CRO
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Peripheral Arterial Disease.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 12, 2017
Lead Product(s) : Sulodexide
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Poseidon CRO
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Sulodexide
Therapeutic Area : Hematology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Postthrombotic Syndrome.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 31, 2015
Lead Product(s) : Sulodexide
Therapeutic Area : Hematology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Sulodexide
Therapeutic Area : Nephrology
Study Phase : Phase IV
Sponsor : ALFA WASSERMANN(BJ) Market Research and Management Co., Ltd
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients
Details : Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Diabetic Nephropathies.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 16, 2011
Lead Product(s) : Sulodexide
Therapeutic Area : Nephrology
Highest Development Status : Phase IV
Sponsor : ALFA WASSERMANN(BJ) Market Research and Management Co., Ltd
Deal Size : Inapplicable
Deal Type : Inapplicable
